The obtained data indicate that compound 6d enhances the action of Tpc specifically through the inhibition of TDP1 and emphasize the significance of this enzyme as a target for increasing the efficiency of cancer therapy with topoisomerase 1 inhibitor drugs. The gene discussed is TDP1; the disease is cancer.